脂肪肝
失调
胃肠病学
非酒精性脂肪肝
内科学
疾病
医学
肠道菌群
2型糖尿病
2型糖尿病
糖尿病
免疫学
内分泌学
作者
K. O. Lytvynenko,Bodnar Pm,T O Lysiana,I. H. Ponomarova,Koval'chuk Oa
出处
期刊:PubMed
[National Institutes of Health]
日期:2015-05-08
卷期号: (5-6): 82-7
被引量:2
摘要
High prevalence of type 2 diabetes mellitus (DM) and nonalcoholic fatty liver disease (NAFLD) contributes to the intensification of scientific research the aim of which is to improve existing treatment. It is given the data about the state of intestinal microbiota in 64 patients with type 2 DM and NAFLD, 26 patients with type 2 DM and 28--with NAFLD. The research revealed significant changes in microbiota composition in patients with type 2 DM combined with NAFLD. Decompensated dysbiosis was registered in 71.9% of patients in this group which manifested in increased quantitative indicators of transient microflora crop with pathogenic characteristics and lack of microflora with protective characteristics.
科研通智能强力驱动
Strongly Powered by AbleSci AI